1. Home
  2. BCDA vs AREB Comparison

BCDA vs AREB Comparison

Compare BCDA & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • AREB
  • Stock Information
  • Founded
  • BCDA N/A
  • AREB 2014
  • Country
  • BCDA United States
  • AREB United States
  • Employees
  • BCDA N/A
  • AREB N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • BCDA Health Care
  • AREB Industrials
  • Exchange
  • BCDA Nasdaq
  • AREB Nasdaq
  • Market Cap
  • BCDA 10.1M
  • AREB 8.4M
  • IPO Year
  • BCDA N/A
  • AREB N/A
  • Fundamental
  • Price
  • BCDA $1.92
  • AREB $1.16
  • Analyst Decision
  • BCDA Strong Buy
  • AREB
  • Analyst Count
  • BCDA 1
  • AREB 0
  • Target Price
  • BCDA $25.00
  • AREB N/A
  • AVG Volume (30 Days)
  • BCDA 651.7K
  • AREB 253.0K
  • Earning Date
  • BCDA 08-11-2025
  • AREB 08-26-2025
  • Dividend Yield
  • BCDA N/A
  • AREB N/A
  • EPS Growth
  • BCDA N/A
  • AREB N/A
  • EPS
  • BCDA N/A
  • AREB N/A
  • Revenue
  • BCDA N/A
  • AREB $9,474,958.00
  • Revenue This Year
  • BCDA N/A
  • AREB N/A
  • Revenue Next Year
  • BCDA N/A
  • AREB N/A
  • P/E Ratio
  • BCDA N/A
  • AREB N/A
  • Revenue Growth
  • BCDA N/A
  • AREB N/A
  • 52 Week Low
  • BCDA $1.63
  • AREB $1.08
  • 52 Week High
  • BCDA $4.66
  • AREB $193.48
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 44.99
  • AREB 35.95
  • Support Level
  • BCDA $1.65
  • AREB $1.22
  • Resistance Level
  • BCDA $1.85
  • AREB $1.37
  • Average True Range (ATR)
  • BCDA 0.13
  • AREB 0.10
  • MACD
  • BCDA -0.01
  • AREB 0.00
  • Stochastic Oscillator
  • BCDA 40.30
  • AREB 25.00

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: